soul trial oral semaglutide cardiovascular outcomes 2024 2025 results Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π SOUL trial shows oral semaglutide
Description
Health Coaching Summer 2024: Thursdays 5:15-6:30 PM Small Group Coaching for Individuals on GLP-1 Medications: Ozempic, Wegovy, Mounjaro Join our specialized small group coaching sessions designed for individuals using GLP-1 medications such as Ozempic, Wegovy, and Mounjaro
Transform health with personalized weight loss programs in Melbourne
If youre taking a GLP-1 you may notice weight loss
Designed to assist with weight management and metabolic health.
If you were prescribed a wrong dose or picked up an inaccurate prescription for a GLP-1 you may have a claim for pharmaceutical negligence.
